I National Conference on Biosimilars – Biosimilars: evidence and efficiency

Events

January 24, 2017Events
On January 24, 2017, in Madrid, the I National Conference on Biosimilars entitled "Normal and Clinical Vision" took place, chaired by the Deputy Director General of Quality of Medicines and Health Products, with numerous attendees.

PROGRAM PHOTOS

PRESENTATIONS

Legal environment and current status of biosimilar medicines in the SNS
Nieves Martin Nephew
Pharmacy Technical Director
Regional Health Management of Castilla y León

OPEN

The value of the biosimilar drug in clinical practice - Inflammatory Bowel Disease
Pillar We
Director of the Digestive Diseases Area of ​​the Hospital

OPEN

BIOSIMILAR Certainties… and uncertainties?
Gonzalo Calvo Rojas
Clinical Pharmacologist, Hospital Clínic de Barcelona

OPEN

The value of the biosimilar drug in clinical practice
Miguel Martin
Head of the Medical Oncology Service, Hospital Gegorio Marañón, President SEOM 2016-2018

OPEN

The regulation of biosimilar medicines in the European Union
Cesar Hernandez Garcia
Head of the Department of Medicines for Human Use. Spanish Agency for Medicines and Health Products.

OPEN

BioSim Newsletter

Subscribe to receive a weekly summary of current events on biosimilar medicines in your email.

SUBSCRIBE